Vancouver selected for international conference on HIV

IAS 2015 the world’s largest international open scientific conference on HIV/AIDS, will be held in Vancouver July 2015

Vancouver, B.C. (July 3, 2013) – Vancouver has been selected to host the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015). The announcement was made during the close of this year’s IAS conference in Kuala Lumpur, Malaysia.

In remarks presented to delegates attending this year’s conference, British Columbia Premier Christy Clark welcomed the selection of Vancouver as host of the 2015 conference.

“On behalf of all British Columbians, I look forward to Vancouver hosting the 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention in 2015,” said Premier Clark.”British Columbia has been progressive in response to the HIV crisis, and remains committed to bringing science and policy together. We’re proud to share our successes with the world in 2015.”

Held every two years, the IAS conference is a unique forum for scientists, clinicians, public health experts and community leaders to examine the latest developments in HIV science and explore how such developments can be realistically applied in implementation programs.

“The IAS conferences truly are exceptional gatherings for all those involved in the field of HIV,” said Dr. Julio Montaner, director of the BC Centre for Excellence in HIV/AIDS (BC-CfE) and IAS 2015 Local Co-Chair.”At the IAS conference in Vancouver in 1996, we introduced highly active antiretroviral therapy (HAART), changing the face of HIV forever. I look forward to making IAS 2015 another landmark in the global response to the HIV epidemic.”

Vancouver was selected to host IAS 2015 following an evaluation of candidate cities conducted by the IAS Governing Council using three main criteria: impact on the epidemic, sufficient infrastructure, and freedom of movement and travel for people living with HIV and AIDS.

“We are excited IAS 2015 will be held in Vancouver,” said Prof. Chris Beyrer, IAS 2015 International Chair, IAS President-Elect and Professor of Epidemiology and International Health at the Johns Hopkins Bloomberg School of Public Health in Baltimore, Maryland.”British Columbia has a long history of leadership in HIV and AIDS. By developing ground-breaking policies such as Treatment as Prevention, they are making significant inroads against HIV and AIDS and providing best practices to implement in Canada and the rest of the world.”

British Columbia has implemented innovative programs to advance the fight against HIV/AIDS. Widespread seek-and-treat for HIV testing and treatment, harm reduction approaches such as syringe exchanges, and the only supervised injection facility in North America have all contributed to a marked decrease in morbidity, mortality, and new HIV cases in the province. Researchers continue to investigate the potential of providing treating high-risk HIV exposures with highly active antiretroviral therapy, decriminalizing sex work, and public health approaches to drug policy as additional opportunities to further reduce HIV transmissions.

IAS 2015 will be organized by the IAS in partnership with the University of British Columbia Division of AIDS, based at St. Paul’s Hospital, Providence Health Care. The conference is expected to gather some 6,000 delegates including 300 media representatives. The conference will take place at the Vancouver Convention Centre, July 19-22, 2015.

Search engine friendly content

-30-

About the British Columbia Centre for Excellence in HIV/AIDS
The BC Centre for Excellence in HIV/AIDS (BC-CfE) is Canada’s largest HIV/AIDS research, treatment and education facility and is internationally recognized as an innovative world leader in combating HIV/AIDS and related diseases. BC-CfE is based at St. Paul’s Hospital, Providence Health Care, a teaching hospital of the University of British Columbia. The BC-CfE works in close collaboration with key provincial stakeholders, including health authorities, health care providers, academics from other institutions, and the community to decrease the health burden of HIV and AIDS. By developing, monitoring and disseminating comprehensive research and treatment programs for HIV and related illnesses, the BC-CfE helps improve the health of British Columbians living with HIV.

About the University of British Columbia
The University of British Columbia (UBC) is one of North America’s largest public research and teaching institutions, and one of only two Canadian institutions consistently ranked among the world’s 40 best universities. Surrounded by the beauty of the Canadian West, it is a place that inspires bold, new ways of thinking that have helped make it a national leader in areas as diverse as community service learning, sustainability and research commercialization. UBC offers more than 55,000 students a range of innovative programs and attracts $550 million per year in research funding from government, non-profit organizations and industry through 7,000 grants.

For additional information or to request interviews, please contact:

Kevin Hollett
BC-CfE
Phone: 604-682-2344 ext. 66536
Mobile: 778-848-3420
Email: khollett@bccfe.ca

Share the Post:
Scroll to Top

During the Canada Post strike, the following measures have been undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office.  (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During this time, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service.